Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 267 followers
Latest posts
Last updated 10 minutes ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Status: Authorised
12 minutes ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
14 minutes ago
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
22 minutes ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
32 minutes ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Orphan designation: bexmarilimab Treatment of myelodysplastic syndromes, 25/03/2025 Positive
about 1 hour ago
Orphan designation: bexmarilimab Treatment of myelodysplastic syndromes, 25/03/2025 Positive
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan...
Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive
about 2 hours ago
Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral...
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation...
Orphan designation: Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains Treatment
about 3 hours ago
Orphan designation: Autologous T lymphocyte-enriched population of cells transduced with a lentiviral...
Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive
about 3 hours ago
Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive
Orphan designation: deucrictibant monohydrate Treatment of bradykinin-mediated angioedema, 25/03/2025 Positive
about 3 hours ago
Orphan designation: deucrictibant monohydrate Treatment of bradykinin-mediated angioedema, 25/03/2025 Positive
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation...